Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021

IMPORTANCE: Medicaid is the largest payer of substance use disorder treatment in the US and plays a key role in responding to the opioid epidemic. However, as recently as 2017, many state Medicaid programs still did not cover the full continuum of clinically recommended care. OBJECTIVE: To determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoulders, Angela, Andrews, Christina M., Westlake, Melissa A., Abraham, Amanda J., Grogan, Colleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422193/
https://www.ncbi.nlm.nih.gov/pubmed/37566428
http://dx.doi.org/10.1001/jamahealthforum.2023.2502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422193/
https://www.ncbi.nlm.nih.gov/pubmed/37566428
http://dx.doi.org/10.1001/jamahealthforum.2023.2502

Ejemplares similares